Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-04-01

Clinical Trial Update: Pilot Study Evaluating the Efficacy of a Topical PDE4 Inhibitor for Morphea [Phase 2]

View source ↗

Summary

A Phase 2 pilot study assessing topical PDE4 inhibitor for morphea has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Duke University | Conditions: Morphea | Phase 2 | Status: COMPLETED | Results posted: 2021-04-01